Pediatric Allergic Rhinitis: Antihistamine Selection

Storms W , Meltzer EO , Nathan R , Selner JC . The economic impact of allergic rhinitis. J Allergy Clin Immunol. 1997;99:S820-S824.

US Dept of Health and Human Services. AHRQ, Pub no. 02-E023, May 2002.

Sibbald B . Epidemiology of allergic rhinitis. In: ML B , ed. Epidemiology of Clinical Allergy. Monographs in Allergy. Basel, Switzerland: Karger; 1993: 61-69.

Bousquet J , Van Cauwenberge P , Khaltaev N , Aria Workshop Group , World Health Organization . Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147-S334.

Druce HM . Allergic and nonallergic rhinitis. In: Allergy: Principles and Practice. 4th ed. St. Louis: Mosby; 1993:1433-1453.

International Consensus Report on Diagnosis and Management of Rhinitis . International Rhinitis Management Working Group. Allergy. 1994;49(19 Suppl):1-34.

Dykewicz MS , Fineman S . Executive Summary of Joint Task Force Practice parameters on diagnosis and management of rhinitis. Ann Allergy Asthma Immunol. 1998;81:463-468.

Fagin J , Friedman R , Fireman P . Allergic rhinitis. Pediatr Clin North Am. 1981;28:797-806.

Meltzer EO . Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol. 2001;108(1 Suppl):S45-S53.

Meltzer EO , Nathan RA , Selner JC , Storms W . Quality of life and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol. 1997;99:S815-S819.

Vuurman EFPM , van Veggel LMA , Uiterwijk MMC , Leutner D , O’Hanlon JF . Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy. 1993;71:121-126.

McMennamin P . Costs of hay fever in the United States in 1990. Ann Allergy. 1994;73:35-39.

Simons FER . H1-antihistamines in children. In: Simons FER , ed: Histamine and H1-Antihistamines in Allergic Disease, 2nd ed. New York: Marcel Dekker; 2002:437-464.

Settipane RA . Complications of allergic rhinitis. Allergy Asthma Proc. 1999;20:209-213.

Casale TB , Blaiss MS , Gelfand E , et al. First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol. 2003;111:S835-S828.

Howarth P . The choice of an H1-antihistamine for the 21st century. Clin Exp All Rev. 2002;2:1-8.

Babe KS , Serafin WE . Histamine, bradykinin, and their antagonists. In: Hardman G , Limbird LE , Molinoff PB , et al. , eds. The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill, 1996:581-600.

Jumbelic MI , Hanzlick R , Cohle S . Alkylamine antihistamine toxicity and review of pediatric registry of the National Association of Medical Examiners. Am J Forensic Med Pathol. 1997;18:65-69.

Garza MB , Osterhoudt KC , Rutstein R . Central anticholinergic syndrome from orphenadrine in a 3-year-old. Pediatr Emerg Care. 2000;16:97-96.

Goetz CM , Lopez G , Dean BS , Krenzelok EP . Accidental childhood death from diphenhydramine overdosage. Am J Emerg Med. 1990;8:321-322.

Le Blaye I , Donatini B , Hall M , et al. Acute ketotifen overdosage. A review of present clinical experience. Drug Safety. 1992;7:387-392.

Lutsky BN , Klose P , Melon J , Krupp P . A comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of 3- to 6-year-old children with seasonal allergic rhinitis. Clin Ther. 1993;15(5):855-865.

Salmun LM , Herron JM , Banfield C , Padhi D , Lorber R , Affrime MB . The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Clin Ther. 2000;22(5):613-621.

Tinkelman CG , Kemp J , Mitchell DQ , et al. Treatment of seasonal allergic rhinitis in children with cetirizine or chlorpheniramine: a multicenter study. Pediatr Asthma Allergy Immunol. 1996;10:9-17.

Masi M , Candiani R , van de Venne H . A placebo-controlled trial of cetirizine in seasonal allergic rhinito-conjuctivitis in children aged 6 to 12 years. Pediatr Allergy Immunol. 1993;4(4 Suppl):47-52.

Allegra L , Paupe J , Wieseman HG . Cetirizine for seasonal allergic rhinitis in children aged 2-6 years. Pediatr Allergy Immunol. 1993;4:157-161.

Ciprandi G , Tosca M , Ricca Vm Passalacqua G , Riccio AM , Bagnasco M , et al. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity. Clin Exp Allergy. 1997;27(10):1160-1166.

Pearlman DS , Lumry WR , Winder JA , Noonan MJ . Once-daily cetirizine effective in the treatment of seasonal allergic rhinitis in children aged 6 to 11 years: a randomized, double-blind, placebo-controlled study. Clin Pediatr. 1997;36(4):209-215.

Diepgen TL . Early Treatment of the Atopic Child Study Group Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. Pediatr Allergy Immunol. 2002;13(4):278-286.

Simons FE , Silas P , Portnoy JM , Portnoy JM , Catuogno J , Chapman J . Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo controlled study. J Allergy Clin Immunol. 2003;111:1244-1248.

Ng KH , Chong D , Wong CK , Ong HT , Lee CY , Lee BW . Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics. 2004;113:e116-e121.

Hindmarch I , Shamsi Z . Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side effects. Clin Exp Allergy. 1999;29(suppl 3):133-144.

Wahn U , Meltzer EO , Finn AF , Kowalski ML , Decosta P , Helin G . Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis. J Allergy Clin Immunol. 2003;111(4):763-769.

Simons FE , Bergman JN , Watson WT , Simons KJ . The clinical pharmacology of fexofenadine in children. J Allergy Clin Immunol. 1996;98(6 Pt 1):1062-1064.

Graft DF , Bernstein DI , Goldsobel A , Meltzer EO , Pornoy J , Long J . Safety of fexofenadine in children treated for seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2001;87:22-26.

Lanier R , Hampel FC , Milgrom H , et al. Fexofenadine has a similar safety and tolerability profile to placebo in children aged 2-5 years. Proceedings of the 22nd EAACI Congress 2003:238.

Lieberman PL , Settipane RA . Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis. Allergy Asthma Proc. 2003;24(2):95-105.

Wober W , Diez Crespo CD , Bahre M . Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age. Arzneimittelforschung. 1997;47:841-844.

Azelastine Product Information. Available at http://www.astelin.com/healthcare/pi.html. Accessed September 2004.

Salib RJ , Howarth PH . Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf. 2003;26(12):863-893.

Shamsi Z , Hindmarch I . Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol Clin Exp. 2000;15:S3-S30.

Mann RD , Pearce GL , Dunn N , Shakir S . Sedation with ‘nonsedating’ antihistamines: four prescription-event monitoring studies in general practice. BMJ. 2000;320:1184-1186.

Tashiro M , Mochizuki H , Iwabuchi K , Sakurada Y , Itoh M , Watanabe T . Roles of histamine in regulation of arousal and cognition: functional neuroimagine of histamine H1 receptors in human brain. Life Sci. 2002;72:409-414.

Golden SJ , Craig TJ . Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis. J Am Osteopath Assoc. 1999;99(7 Suppl):S7-S12.

Day JH , Briscoe M , Widlitz MD . Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol. 1998;101:638-645.

Horak F , Stuber P , Zieglmayer R , Kavina A , De Vos C , Burtin B , et al. Controlled comparison of the efficacy and safety of cetirizine 10 mg OD and fexofenadine 120 mg OD in reducing symptoms of seasonal allergic rhinitis. Int Arch Allergy Immunol. 2001;125:73-80.

Day JH , Briscoe MP , Welsh A . Onset of action, efficacy and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol. 1997;79:533-540.